Use of oral complementary-alternative medicine (OCAM) and fatigue among early breast cancer (BC) patients (pts)

Background: Use of OCAM varies widely among cancer pts, ranging 20 – 80%. Efficacy of OCAM for cancer-related symptoms including fatigue is controversial, while some interactions with standard anticancer therapy were reported. We aimed to describe factors associated with use of OCAM, particularly its relationship with self-reported fatigue in BC pts.

Source: European Journal of Cancer - September 30, 2020 Category: Cancer & Oncology Authors: N. Djehal, J. Havas, A. Gbenou, E. Martin, C. Charles, S. Dauchy, B. Pistilli, C. Cadeau, P. Arveux, S. Everhard, J. Lemonnier, C. Coutant, P. Cottu, A. Lesur, G. Menvielle, A. Dumas, F. Andre, S. Michiels, I. Vaz-Luis, A. Di Meglio Tags: POSTERS A: Rehabilitation/Survivorship Source Type: research